Project 3 - Human colonoids as a model for the pathobiology of EHEC
Project 3 - Human colonoids as a model for the pathobiology of EHEC
批准号:
9150902
负责人:
JAMES B KAPER
金额:
$28.95万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAdherent CultureAdoptedAnimal ModelAntibioticsApicalBacterial Attachment SiteBiopsyCell LineCellsCessation of lifeCharacteristicsChloride IonChloridesClinical DataCoculture TechniquesColonComplexDataDevelopmentDiarrheaDiseaseEnteralEnteroendocrine CellEpithelialEpithelial CellsEpitheliumEscherichia coliEscherichia coli EHECEscherichia coli InfectionsEtiologyFaceGoblet CellsGrantHemolytic-Uremic SyndromeHemorrhagic colitisHospitalizationHumanImmuneImmune responseInfectionIntestinal DiseasesIntestinesIon TransportIonsLifeMedicalModelingMolecularMolecular ProfilingMucous body substanceOrganoidsPathogenesisPatientsPlayProductionRiskRodent ModelRoleSeptic ToxemiaSerine ProteaseShiga ToxinShigella InfectionsSurfaceSystemSystemic diseaseTechnologyTestingThickVirulenceVirulence Factorsabsorptionabstractingadult stem cellbasecellular microvilluscolon cancer cell linecytokineeffective therapyfoodbornehuman diseasehuman stem cellshuman subjectimprovedindividual patientinsightintestinal epitheliummacrophagemicrobialmonolayerneutrophilnew therapeutic targetnovelnovel therapeutic interventionpathogenresearch studystem cell biology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The proposed studies will advance the understanding of enteric disease caused by food-borne, Shiga-toxin-
producing enterohemorrhagic E. coli (EHEC), whichis the major cause of life-threatening hemorrhagic colitis
and hemolytic uremic syndrome in the US. While Shiga toxin 2a is the main virulence factor for intestinal and
extra-intestinal disease manifestations, clinical data strongly suggest that Stx-toxemia occurs early in illness
and is short-lived. Thus, our studies will focus on early EHEC-host interactions, particularly the complex
interaction between EHEC and the human colonocyte, goblet cells and immune cells, including macrophages
and neutrophils. Our exciting preliminary data are gained using a novel model of EHEC infection, termed
human colonoid monolayers (HCM), which are primary colonic epithelial cultures derived from adult stem cells
isolated from colonic biopsies of healthy donors. Upon differentiation, HCM are composed of all major types of
epithelial cells, including colonocyte, goblet and enteroendocrine cells. They develop mature microvilli and
produce a thick layer of mucus similar to that which is normally present in the human colon. Using these HCM
we are demonstrating here that EHEC infection results in the destruction of the mucus layer allowing EHEC to
gain access to the colonocyte surface. The serine protease EspP plays a role in EHEC colonization and also
induces the ion secretion, indicating its role in EHEC-induced watery diarrhea. These data suggest that human
colonoids recapitulate EHEC infection and provide unique insights into pathogenesis that differ from other
studies performed in human colon cancer cell lines, allowing improved appreciation of the roles of virulence
factors and assessment of novel therapeutic targets. Relevant to this pathogen, we will test the hypothesis that
HCM, which uniquely represent ex vivo human colonic epithelium, recapitulate human EHEC infection and
provide unique insights in pathogenesis. To test this hypothesis and enhance our understanding of EHEC
intestinal pathogenesis, we propose the following Aims: 1. Determine the role of serine protease EspP in
EHEC colonization of human colonic epithelium and virulence development. 2. Determine the molecular
mechanisms of EHEC induced watery diarrhea. 3. Determine the role of macrophages and neutrophils in
EHEC-induced immune response. The results gained from the proposed experiments will further elucidate the
molecular mechanisms for EHEC interactions with human colonic epithelium, test the role of EspP serine
protease in EHEC colonization and development of watery diarrhea as well as establish the role of neutrophil
and macrophages in EHEC clearance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Maryland FIRST Program
-
批准号:10701024
-
项目类别:
-
资助金额:$410.13万
-
财政年份:2022
-
负责人:JAMES B KAPER
-
依托单位:
Administrative Core-UM First
-
批准号:10494945
-
项目类别:
-
资助金额:$17.83万
-
财政年份:2022
-
负责人:JAMES B KAPER
-
依托单位:
University of Maryland FIRST Program
-
批准号:10494944
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2022
-
负责人:JAMES B KAPER
-
依托单位:
Administrative Core-UM First
-
批准号:10701025
-
项目类别:
-
资助金额:$376.64万
-
财政年份:2022
-
负责人:JAMES B KAPER
-
依托单位:
Administrative Core
-
批准号:10190299
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2016
-
负责人:JAMES B KAPER
-
依托单位:
Administrative Core
-
批准号:10686821
-
项目类别:
-
资助金额:$12.59万
-
财政年份:2016
-
负责人:JAMES B KAPER
-
依托单位:
Administrative Core
-
批准号:10427389
-
项目类别:
-
资助金额:$12.49万
-
财政年份:2016
-
负责人:JAMES B KAPER
-
依托单位:
Severe Enteric Disease: Pathogenesis and Response
-
批准号:8292147
-
项目类别:
-
资助金额:$140.95万
-
财政年份:2010
-
负责人:JAMES B KAPER
-
依托单位:
Severe Enteric Disease: Pathogenesis and Response
-
批准号:8683079
-
项目类别:
-
资助金额:$145.52万
-
财政年份:2010
-
负责人:JAMES B KAPER
-
依托单位:
Severe Enteric Disease: Pathogenesis and Response
-
批准号:7991524
-
项目类别:
-
资助金额:$151.25万
-
财政年份:2010
-
负责人:JAMES B KAPER
-
依托单位:
Severe Enteric Disease: Pathogenesis and Response
-
批准号:8113434
-
项目类别:
-
资助金额:$145.43万
-
财政年份:2010
-
负责人:JAMES B KAPER
-
依托单位:
Severe Enteric Disease: Pathogenesis and Response
-
批准号:8496672
-
项目类别:
-
资助金额:$136.79万
-
财政年份:2010
-
负责人:JAMES B KAPER
-
依托单位:
NOVEL E. COLI 0157:H7 INTESTINAL COLONIZATION FACTORS
-
批准号:6288364
-
项目类别:
-
资助金额:$26.03万
-
财政年份:2000
-
负责人:JAMES B KAPER
-
依托单位:
NOVEL E. COLI 0157:H7 INTESTINAL COLONIZATION FACTORS
-
批准号:6381959
-
项目类别:
-
资助金额:$24.31万
-
财政年份:2000
-
负责人:JAMES B KAPER
-
依托单位:
NOVEL E. COLI 0157:H7 INTESTINAL COLONIZATION FACTORS
-
批准号:6500832
-
项目类别:
-
资助金额:$6.83万
-
财政年份:2000
-
负责人:JAMES B KAPER
-
依托单位:
NOVEL E. COLI 0157:H7 INTESTINAL COLONIZATION FACTORS
-
批准号:6524353
-
项目类别:
-
资助金额:$24.24万
-
财政年份:2000
-
负责人:JAMES B KAPER
-
依托单位:
Novel E. Coli 0157:H7 Intestinal Colonization Factors
-
批准号:6968813
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2000
-
负责人:JAMES B KAPER
-
依托单位:
Novel E. Coli 0157:H7 Intestinal Colonization Factors
-
批准号:7488582
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2000
-
负责人:JAMES B KAPER
-
依托单位:
NOVEL E. COLI 0157:H7 INTESTINAL COLONIZATION FACTORS
-
批准号:6611049
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2000
-
负责人:JAMES B KAPER
-
依托单位:
NOVEL E. COLI 0157:H7 INTESTINAL COLONIZATION FACTORS
-
批准号:6609453
-
项目类别:
-
资助金额:$8.71万
-
财政年份:2000
-
负责人:JAMES B KAPER
-
依托单位:
海外基金